L-Ascorbyl Glucoside is primarily used for its role in protecting the skin against oxidative stress. It thus helps the skin to combat free radicals, unstable molecules that, by reacting with cellular components, can degrade them. Free radicals can in particular disrupt the network of collagen and elastin in the extracellular matrix and accelerate skin laxity and the appearance of wrinkles. Regular use of antioxidants, such as ascorbyl glucoside, helps to prevent this phenomenon.
A comparative study on human skin explants evaluated the cutaneous delivery, stability and antioxidant efficacy of a formulation containing 1.8% ascorbyl glucoside, compared with another containing 15% ascorbic acid. The results show that ascorbyl glucoside is completely converted into ascorbic acid by the skin before crossing the skin barrier, while leaving a non-metabolised fraction in the tissues, thus constituting a reservoir available for subsequent conversion. This kinetic profile suggests a sustained antioxidant action over time, rather than a transient peak in activity.
From a functional perspective, the antioxidant efficacy was evaluated using several oxidative stress markers, including malondialdehyde (MDA), superoxide dismutase (SOD) and catalase. Although the absolute amount of ascorbic acid in the skin was higher following direct application of ascorbic acid, both formulations exhibited equivalent antioxidant protection across all measured parameters. These findings suggest that a lower concentration of Ascorbyl Glucoside can offer efficacy comparable to that of ascorbic acid, whilst providing superior chemical stability.
Ascorbyl Glucoside is also under investigation for its potential depigmenting effect. It works by modulating the activity of tyrosinase, a key enzyme in melanin synthesis, which may help to gradually reduce hyperpigmentation and achieve a more even skin tone. A clinical study involving 27 Japanese women with solar lentigines assessed the effect of a 28% lotion containing an Ascorbyl Glucoside–arginine derivative complex (AGAC), applied twice daily for 24 weeks to one side of the face, compared with a placebo on the other side. The results showed a significant decrease in pigmentation scores in the treated area compared with placebo as early as 12 weeks, with even more pronounced effects at 24 weeks. However, the numerical values were not disclosed by the researchers.
This suggests that ascorbyl glucoside could be relevant for preventing and addressing the signs of photoageing.
Note : Studies in vitro have also shown that ascorbyl glucoside inhibits the activity of collagenase and elastase, two enzymes respectively responsible for the degradation of collagen and elastin. This mechanism of action, if confirmed in vivo, could also be useful in combating signs of skin ageing.